

The Science and Supply of GLP-1s
42 snips Jun 19, 2024
Brooke Boyarsky-Pratt, the CEO of KnownWell, revolutionizes the obesity medicine landscape with her personal journey battling obesity. She discusses the critical role of obesity-specific practitioners and patient-centric medical homes in fostering trust. The conversation delves into the science and impact of GLP-1 medications, highlighting their tailored applications in treatment. The challenges of cost and supply in the obesity sector are addressed, alongside a vision for a more empathetic, comprehensive approach to obesity care.
AI Snips
Chapters
Transcript
Episode notes
Brooke's Inspiration
- Brooke Boyarsky-Pratt's pediatrician suggested "fat camp", negatively impacting her healthcare interactions.
- This experience fueled her passion to create patient-centered care for individuals with obesity.
Obesity Medicine Defined
- Obesity medicine is a medical specialty focusing on comprehensive treatment of overweight and obesity.
- It addresses weight loss and related conditions like diabetes and hyperlipidemia.
PCP Challenges
- Primary care doctors often lack sufficient training and resources for effective obesity management.
- They may struggle with medication understanding, approvals, and providing wraparound services.